CCND1 and atypical teratoid rhabdoid tumor: miR-17-92 (miR-19a, miR-17 and miR-20a): Increased MIR17HG expression, a gene encoding a cluster of six miRNAs (miR-17-92) conferred sensitivity to palbociclib treatment in atypical teratoid rhabdoid tumors (ATRTs) via suppression of the cyclin D1 protein [47].